top of page
The Professional Network for Healthcare Experts
FDA approves Roche HER2 companion diagnostics for metastatic gastroesophageal adenocarcinoma
The FDA has expanded approval of two Roche HER2 companion diagnostics to identify patients with metastatic gastroesophageal adenocarcinoma who may be eligible for ZIIHERA treatment.
nuaxia
Sep 242 min read
Boehringer Ingelheim and Envisagenics sign oncology collaboration worth more than $1bn
Boehringer Ingelheim and Envisagenics have entered a multi-year oncology collaboration worth more than $1 billion to discover therapeutic targets created by alternative RNA splicing.
nuaxia
Sep 232 min read
Cureety acquires Reimagine Care to expand precision oncology platform
The acquisition combines Cureety's therapy-specific oncology monitoring platform with Reimagine Care's AI-enabled virtual cancer-care capabilities.
nuaxia
Sep 42 min read
bottom of page